PMID: 16623610Apr 21, 2006Paper

Adherence to the NASPE guideline for amiodarone monitoring at a medical university

Journal of Managed Care Pharmacy : JMCP
Courtney L Bickford, Anne P Spencer

Abstract

Amiodarone is an effective antiarrhythmic, but the clinical usefulness of this agent is complicated by its extensive side-effect profile, which necessitates careful patient selection and frequent monitoring. The purpose of this study was to quantify adherence to published recommendations for baseline monitoring when initiating inpatient amiodarone therapy at a university teaching hospital and determine whether appropriate serial monitoring of chronic amiodarone therapy (>or= 6 months) is occurring in the outpatient setting. A retrospective review of electronic medical records was conducted for inpatients at the Medical University of South Carolina (MUSC) who received amiodarone between November 1, 2003, and March 31, 2004, and for a subset of outpatients who had received amiodarone therapy for at least 6 months. Their medical records were reviewed for demographic data; reason for, date of initiation of, and duration of amiodarone therapy; and the occurrence of laboratory and diagnostic tests. The amiodarone guideline from the North American Society of Pacing and Electrophysiology (NASPE) was used as the measure of appropriate monitoring for baseline and follow-up chest x-rays (CXRs), liver function tests (LFTs), thyroid functio...Continue Reading

Citations

Mar 14, 2020·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·David HamiltonAnthony Hilliard
Aug 16, 2016·Journal of Evaluation in Clinical Practice·Chun-Jui HuangLiang-Yu Lin
Oct 25, 2017·JAAPA : Official Journal of the American Academy of Physician Assistants·Rebecca Colby, Holly Geyer
Feb 21, 2008·Wiener medizinische Wochenschrift·Peter Mikosch
May 7, 2009·The Annals of Pharmacotherapy·Michael H KimDavid S Battleman
Jun 4, 2010·Critical Care Medicine·Zachariah ThomasAtul Malhotra
Aug 20, 2011·The Annals of Pharmacotherapy·Jennifer TjiaTerry S Field

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.